No Data
No Data
Lianlong (300596) 2024 Quarterly Report Review: 24Q1 profit increased month-on-month and continued to monitor the progress of new production capacity and new product implementation
Event: The company released its 2024 quarterly report. 2024Q1, the company achieved revenue of 1,354 billion yuan in a single quarter, an increase of 14.17% year on year and a decrease of 4.71% month on month; realized net profit to mother of 107 million yuan, year over year
Lianlong (300596) Comment: The performance is basically in line with expectations, the anti-aging boom continues to increase market share, and the market share of lubricant additives is about to be launched
Company announcement: The company released its 2023 annual report. During the reporting period, it achieved operating income of 5.278 billion yuan (YoY +9.0%), net profit attributable to mother of 362 million yuan (YoY -31.05%), and net profit not attributable to mother 3.
China Galaxy released a research report on April 28 stating that it gave Lianlong (300596.SZ) a recommended rating. The main reasons for the rating include: 1) the market share of production capacity expansion is increasing, and the leading position of an
China Galaxy released a research report on April 28 stating that it gave Lianlong (300596.SZ) a recommended rating. The main reasons for the rating include: 1) the market share of production capacity expansion is increasing, and the leading position of anti-aging agents continues to be consolidated; 2) domestic replacement space for lubricant additives is vast, awaiting the gradual expansion of Kangtai Phase II; 3) exploring the emerging blue ocean of life science and writing a development blueprint; 4) indirect merger and acquisition of Korea's IPI to lay out a new field of electronic-grade PI. (Mainichi Keizai Shimbun)
Lianlong (300596): Q1 performance continues to improve, and the new sector is becoming more mature
Achieving net profit of 107 million yuan in 24Q1, maintaining the “increase in holdings” rating, Lianlong released its quarterly report for the year 24 on April 26, and achieved revenue of 1,354 billion yuan in 24Q1, yoy +14.2%.
Guojin Securities released a research report on April 28 stating that it gave Lianlong (300596.SZ) an increase in holdings rating. The main reasons for the rating include: 1) the overall anti-aging agent business remains stable; 2) the company's product p
Guojin Securities released a research report on April 28 stating that it gave Lianlong (300596.SZ) an increase in holdings rating. The main reasons for the rating include: 1) the overall anti-aging agent business remains stable; 2) the company's product prices will show an upward trend in 2024. (Mainichi Keizai Shimbun)
Lianlong (300596): Emerging business boosts the company to embark on a new journey
Incident: The company released its 2023 annual report and 2024 quarterly report. The full year of 2023 achieved revenue of 5.278 billion yuan, an increase of 9% over the previous year, and net profit to mother of 362 million yuan, a year-on-year decrease of 31.05%. 20
No Data